Previous studies have demonstrated that tumor cells escape from an immune attack by activating certain immune checkpoints, such as cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and the programmed cell death protein 1 (PD-1), to resist T cell-mediated antitumor immunity [8, 9]. Here, PDCD1 is linked to neoplasm.